연구동향 분석
박사

S1P Lyase as a Novel biomarker in Osteoporosis and Atopic Dermatitis

서초희 2015년

논문상세정보
인용/피인용
' S1P Lyase as a Novel biomarker in Osteoporosis and Atopic Dermatitis' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • 4-dimethylcyclohexanedione
  • atopic dermatitis
  • biomarker
  • bone marrow fluid
  • dansyl-hydrazine
  • dinitro chloro benzene
  • hexadecenal
  • hplc-fld
  • lc-ms/ms
  • osteoporosis
  • oxazolone
  • s1p lyase
  • sphingolipids
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
841 0

0.0%

' S1P Lyase as a Novel biomarker in Osteoporosis and Atopic Dermatitis' 의 참고문헌

  • van der Giet, M., Tolle, M., Kleuser, B., 2008. Relevance and potential of sphingosine-1-phosphate in vascular inflammatory disease. Biological chemistry 389, 1381-1390.
  • Williams, T.I., Lovell, M.A., Lynn, B.C., 2005. Analysis of derivatized biogenicaldehydes by LC tandem mass spectrometry. Analytical chemistry 77, 3383-3389.
  • Vogel, P., Donoviel, M.S., Read, R., Hansen, G.M., Hazlewood, J., Anderson, S.J., Sun,W., Swaffield, J., Oravecz, T., 2009. Incomplete inhibition of sphingosine 1-phosphatelyase modulates immune system function yet prevents early lethality and non-lymphoidlesions. PloS one 4, e4112.
  • Van Veldhoven, P.P., Mannaerts, G.P., 1991. Subcellular localization and membranetopology of sphingosine-1-phosphate lyase in rat liver. The Journal of biologicalchemistry 266, 12502-12507.
  • Sigal, Y.J., McDermott, M.I., Morris, A.J., 2005. Integral membrane lipidphosphatases/phosphotransferases: common structure and diverse functions. TheBiochemical journal 387, 281-293.
  • Serra, M., Saba, J.D., 2010. Sphingosine 1-phosphate lyase, a key regulator ofsphingosine 1-phosphate signaling and function. Advances in enzyme regulation 50, 349-362.
  • Seo, E.Y., Park, G.T., Lee, K.M., Kim, J.A., Lee, J.H., Yang, J.M., 2006. Identificationof the target genes of atopic dermatitis by real-time PCR. The Journal of investigativedermatology 126, 1187-1189.
  • Schwab, S.R., Pereira, J.P., Matloubian, M., Xu, Y., Huang, Y., Cyster, J.G., 2005.Lymphocyte sequestration through S1P lyase inhibition and disruption of S1P gradients.Science 309, 1735-1739.
  • Sanchez, T., Hla, T., 2004. Structural and functional characteristics of S1P receptors.Journal of cellular biochemistry 92, 913-922.
  • Ryu, J., Kim, H.J., Chang, E.J., Huang, H., Banno, Y., Kim, H.H., 2006. Sphingosine 1-phosphate as a regulator of osteoclast differentiation and osteoclast-osteoblast coupling.The EMBO journal 25, 5840-5851.
  • Roelofsen, T., Akkers, R., Beumer, W., Apotheker, M., Steeghs, I., van de Ven, J.,Gelderblom, C., Garritsen, A., Dechering, K., 2008. Sphingosine-1-phosphate acts as adevelopmental stage specific inhibitor of platelet-derived growth factor-inducedchemotaxis of osteoblasts. Journal of cellular biochemistry 105, 1128-1138.
  • Reines, I., Kietzmann, M., Mischke, R., Tschernig, T., Luth, A., Kleuser, B., Baumer, W.,2009. Topical application of sphingosine-1-phosphate and FTY720 attenuate allergiccontact dermatitis reaction through inhibition of dendritic cell migration. The Journal ofinvestigative dermatology 129, 1954-1962.
  • Pyne, S., Pyne, N.J., 2000. Sphingosine 1-phosphate signalling in mammalian cells. TheBiochemical journal 349, 385-402.
  • Pyne, N.J., Long, J.S., Lee, S.C., Loveridge, C., Gillies, L., Pyne, S., 2009. New aspectsof sphingosine 1-phosphate signaling in mammalian cells. Advances in enzymeregulation 49, 214-221.
  • Price, P.A., Parthemore, J.G., Deftos, L.J., 1980. New biochemical marker for bonemetabolism. Measurement by radioimmunoassay of bone GLA protein in the plasma ofnormal subjects and patients with bone disease. The Journal of clinical investigation 66,878-883.
  • Peter, B.F., Lidington, D., Harada, A., Bolz, H.J., Vogel, L., Heximer, S., Spiegel, S.,Pohl, U., Bolz, S.S., 2008. Role of sphingosine-1-phosphate phosphohydrolase 1 in theregulation of resistance artery tone. Circulation research 103, 315-324.
  • Pels, R., Sterry, W., Lademann, J., 2008. Clobetasol propionate--where, when, why?Drugs Today (Barc) 44, 547-557.
  • Oskouian, B., Saba, J., 2007. Sphingosine-1-phosphate metabolism and intestinaltumorigenesis: lipid signaling strikes again. Cell Cycle 6, 522-527.
  • Mizugishi, K., Yamashita, T., Olivera, A., Miller, G.F., Spiegel, S., Proia, R.L., 2005.Essential role for sphingosine kinases in neural and vascular development. Molecular andcellular biology 25, 11113-11121.
  • Min, J., Van Veldhoven, P.P., Zhang, L., Hanigan, M.H., Alexander, H., Alexander, S.,2005. Sphingosine-1-phosphate lyase regulates sensitivity of human cells to select139chemotherapy drugs in a p38-dependent manner. Molecular cancer research : MCR 3,287-296.
  • Min, J., Stegner, A.L., Alexander, H., Alexander, S., 2004. Overexpression ofsphingosine-1-phosphate lyase or inhibition of sphingosine kinase in Dictyosteliumdiscoideum results in a selective increase in sensitivity to platinum-based chemotherapydrugs. Eukaryotic cell 3, 795-805.
  • Merrill, A.H., Jr., 2002. De novo sphingolipid biosynthesis: a necessary, but dangerous,pathway. The Journal of biological chemistry 277, 25843-25846.
  • Mao, C., Obeid, L.M., 2008. Ceramidases: regulators of cellular responses mediated byceramide, sphingosine, and sphingosine-1-phosphate. Biochimica et biophysica acta 1781,424-434.
  • Liu, J., Hsu, A., Lee, J.F., Cramer, D.E., Lee, M.J., 2011. To stay or to leave: Stem cellsand progenitor cells navigating the S1P gradient. World journal of biological chemistry 2,1-13.
  • Li, G., Alexander, H., Schneider, N., Alexander, S., 2000. Molecular basis for resistanceto the anticancer drug cisplatin in Dictyostelium. Microbiology 146 ( Pt 9), 2219-2227.
  • Lee, S.H., Lee, S.Y., Lee, Y.S., Kim, B.J., Lim, K.H., Cho, E.H., Kim, S.W., Koh, J.M.,Kim, G.S., 2012. Higher circulating sphingosine 1-phosphate levels are associated withlower bone mineral density and higher bone resorption marker in humans. The Journal ofclinical endocrinology and metabolism 97, E1421-1428.
  • Lee, M.J., Van Brocklyn, J.R., Thangada, S., Liu, C.H., Hand, A.R., Menzeleev, R.,Spiegel, S., Hla, T., 1998. Sphingosine-1-phosphate as a ligand for the G protein-coupledreceptor EDG-1. Science 279, 1552-1555.
  • Kumar, A., Saba, J.D., 2009. Lyase to live by: sphingosine phosphate lyase as atherapeutic target. Expert opinion on therapeutic targets 13, 1013-1025.
  • Kotani, M., Matsumoto, M., Fujita, A., Higa, S., Wang, W., Suemura, M., Kishimoto, T.,Tanaka, T., 2000. Persimmon leaf extract and astragalin inhibit development of dermatitisand IgE elevation in NC/Nga mice. The Journal of allergy and clinical immunology 106,159-166.
  • Kirby, R.J., Jin, Y., Fu, J., Cubillos, J., Swertfeger, D., Arend, L.J., 2009. Dynamicregulation of sphingosine-1-phosphate homeostasis during development of mousemetanephric kidney. American journal of physiology. Renal physiology 296, F634-641.
  • Kim, M.S., Pyun, H.B., Hwang, J.K., 2014. Panduratin A, an activator of PPARalpha/delta, suppresses the development of oxazolone-induced atopic dermatitis-likesymptoms in hairless mice. Life sciences 100, 45-54.
  • Kim, B.J., Koh, J.M., Lee, S.Y., Lee, Y.S., Lee, S.H., Lim, K.H., Cho, E.H., Kim, S.W.,Kim, T.H., Kim, S.Y., Kim, G.S., 2012. Plasma sphingosine 1-phosphate levels and therisk of vertebral fracture in postmenopausal women. The Journal of clinicalendocrinology and metabolism 97, 3807-3814.
  • Katayama, I., Kohno, Y., Akiyama, K., Ikezawa, Z., Kondo, N., Tamaki, K., Kouro, O.,2011. Japanese guideline for atopic dermatitis. Allergology international : official journalof the Japanese Society of Allergology 60, 205-220.
  • Johnson, K.R., Johnson, K.Y., Becker, K.P., Bielawski, J., Mao, C., Obeid, L.M., 2003. Role of human sphingosine-1-phosphate phosphatase 1 in the regulation of intra- andextracellular sphingosine-1-phosphate levels and cell viability. The Journal of biologicalchemistry 278, 34541-34547.
  • Ishii, M., Kikuta, J., Shimazu, Y., Meier-Schellersheim, M., Germain, R.N., 2010.Chemorepulsion by blood S1P regulates osteoclast precursor mobilization and boneremodeling in vivo. The Journal of experimental medicine 207, 2793-2798.
  • Holthuis, J.C., Pomorski, T., Raggers, R.J., Sprong, H., Van Meer, G., 2001. Theorganizing potential of sphingolipids in intracellular membrane transport. Physiologicalreviews 81, 1689-1723.
  • Holleran, W.M., Takagi, Y., Uchida, Y., 2006. Epidermal sphingolipids: metabolism,function, and roles in skin disorders. FEBS letters 580, 5456-5466.
  • Hait, N.C., Oskeritzian, C.A., Paugh, S.W., Milstien, S., Spiegel, S., 2006. Sphingosinekinases, sphingosine 1-phosphate, apoptosis and diseases. Biochimica et biophysica acta1758, 2016-2026.
  • Grey, A., Xu, X., Hill, B., Watson, M., Callon, K., Reid, I.R., Cornish, J., 2004.Osteoblastic cells express phospholipid receptors and phosphatases and proliferate inresponse to sphingosine-1-phosphate. Calcified tissue international 74, 542-550.
  • Grey, A., Chen, Q., Callon, K., Xu, X., Reid, I.R., Cornish, J., 2002. The phospholipidssphingosine-1-phosphate and lysophosphatidic acid prevent apoptosis in osteoblastic cellsvia a signaling pathway involving G(i) proteins and phosphatidylinositol-3 kinase.Endocrinology 143, 4755-4763.
  • Giussani, P., Maceyka, M., Le Stunff, H., Mikami, A., Lepine, S., Wang, E., Kelly, S.,Merrill, A.H., Jr., Milstien, S., Spiegel, S., 2006. Sphingosine-1-phosphatephosphohydrolase regulates endoplasmic reticulum-to-golgi trafficking of ceramide.Molecular and cellular biology 26, 5055-5069.
  • Gillies, L., Lee, S.C., Long, J.S., Ktistakis, N., Pyne, N.J., Pyne, S., 2009. Thesphingosine 1-phosphate receptor 5 and sphingosine kinases 1 and 2 are localised incentrosomes: possible role in regulating cell division. Cellular signalling 21, 675-684.
  • Fyrst, H., Saba, J.D., 2010. An update on sphingosine-1-phosphate and othersphingolipid mediators. Nature chemical biology 6, 489-497.
  • Dai, Q.G., Zhang, P., Wu, Y.Q., Ma, X.H., Pang, J., Jiang, L.Y., Fang, B., 2014.Ovariectomy induces osteoporosis in the maxillary alveolar bone: an in vivo micro-CTand histomorphometric analysis in rats. Oral diseases 20, 514-520.
  • Cuvillier, O., 2002. Sphingosine in apoptosis signaling. Biochimica et biophysica acta1585, 153-162.
  • Cork, M.J., Robinson, D.A., Vasilopoulos, Y., Ferguson, A., Moustafa, M., MacGowan,A., Duff, G.W., Ward, S.J., Tazi-Ahnini, R., 2006. New perspectives on epidermal barrierdysfunction in atopic dermatitis: gene-environment interactions. The Journal of allergyand clinical immunology 118, 3-21; quiz 22-23.
  • Chalfant, C.E., Spiegel, S., 2005. Sphingosine 1-phosphate and ceramide 1-phosphate:expanding roles in cell signaling. Journal of cell science 118, 4605-4612.
  • Brindley, D.N., Pilquil, C., 2009. Lipid phosphate phosphatases and signaling. Journalof lipid research 50 Suppl, S225-230.
  • Bouxsein, M.L., Boyd, S.K., Christiansen, B.A., Guldberg, R.E., Jepsen, K.J., Muller, R.,2010. Guidelines for assessment of bone microstructure in rodents using micro-computedtomography. Journal of bone and mineral research : the official journal of the AmericanSociety for Bone and Mineral Research 25, 1468-1486.
  • Boguniewicz, M., Leung, D.Y., 2011. Atopic dermatitis: a disease of altered skin barrierand immune dysregulation. Immunological reviews 242, 233-246.
  • Berdyshev, E.V., Goya, J., Gorshkova, I., Prestwich, G.D., Byun, H.S., Bittman, R.,Natarajan, V., 2011. Characterization of sphingosine-1-phosphate lyase activity byelectrospray ionization-liquid chromatography/tandem mass spectrometry quantitation of(2E)-hexadecenal. Analytical biochemistry 408, 12-18.
  • Bartke, N., Hannun, Y.A., 2009. Bioactive sphingolipids: metabolism and function.Journal of lipid research 50 Suppl, S91-96.
  • Bandhuvula, P., Saba, J.D., 2007. Sphingosine-1-phosphate lyase in immunity andcancer: silencing the siren. Trends in molecular medicine 13, 210-217.
  • Bandhuvula, P., Li, Z., Bittman, R., Saba, J.D., 2009. Sphingosine 1-phosphate lyaseenzyme assay using a BODIPY-labeled substrate. Biochemical and biophysical researchcommunications 380, 366-370.
  • Bandhuvula, P., Fyrst, H., Saba, J.D., 2007. A rapid fluorescence assay for sphingosine-1-phosphate lyase enzyme activity. Journal of lipid research 48, 2769-2778.
  • Anne Klibanski, M.D., 2001. Osteoporosis prevention, diagnosis, and therapy. Jama 285,785-795.
  • Alemany, R., van Koppen, C.J., Danneberg, K., Ter Braak, M., Meyer Zu Heringdorf, D.,2007. Regulation and functional roles of sphingosine kinases. Naunyn-Schmiedeberg'sarchives of pharmacology 374, 413-428.